{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:31:51Z","timestamp":1769193111360,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T00:00:00Z","timestamp":1438041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T00:00:00Z","timestamp":1438041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heroin dependence is a severe and chronically relapsing substance use disorder with limited treatment options. Stress is known to increase craving and drug-taking behavior, but it is not known whether the stress hormone cortisol mediates these stress effects or whether cortisol may rather reduce craving, for example, by interfering with addiction memory. The aim of the present study was to determine the effects of cortisol administration on craving in heroin-dependent patients and to determine whether the effects depend on the daily dose of heroin consumption. We used a double-blind, placebo-controlled, cross-over study in 29 heroin-dependent patients in a stable heroin-assisted treatment setting. A single oral dose of 20\u2009mg of cortisol or placebo was administered 105\u2009min before the daily heroin administration. The primary outcome measure was cortisol-induced change in craving. Secondary measures included anxiety, anger and withdrawal symptoms. For the visual analog scale for craving, we found a significant interaction (<jats:italic>P<\/jats:italic>=0.0027) between study medication and heroin-dose group (that is, daily low, medium or high dose of heroin). Cortisol administration reduced craving in patients receiving a low dose of heroin (before heroin administration:<jats:italic>P<\/jats:italic>=0.0019; after heroin administration:<jats:italic>P<\/jats:italic>=0.0074), but not in patients receiving a medium or high dose of heroin. In a picture-rating task with drug-related pictures, cortisol administration did not affect the ratings for the picture-characteristic craving in all the three heroin-dose groups. Cortisol also did not significantly affect secondary outcome measures. In conclusion, a single administration of cortisol leads to reduced craving in low-dose heroin addicts. The present findings might have important clinical implications with regard to understanding stress effects and regarding treatment of addiction.<\/jats:p>","DOI":"10.1038\/tp.2015.101","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T13:42:11Z","timestamp":1438090931000},"page":"e610-e610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effects of cortisol administration on craving in heroin addicts"],"prefix":"10.1038","volume":"5","author":[{"given":"M","family":"Walter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Bentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Schicktanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-3289","authenticated-orcid":false,"given":"A","family":"Milnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Aerni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Gerhards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Schwegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Roozendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U E","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"de Quervain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"BFtp2015101_CR1","unstructured":"UNODC World Drug Report 2014. United Nations: New York, NY, USA, 2014."},{"key":"BFtp2015101_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa0810635","volume":"361","author":"E Oviedo-Joekes","year":"2009","unstructured":"Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009; 361: 777\u2013786.","journal-title":"N Engl J Med"},{"key":"BFtp2015101_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.278.5335.45","volume":"278","author":"AI Leshner","year":"1997","unstructured":"Leshner AI . Addiction is a brain disease, and it matters. Science 1997; 278: 45\u201347.","journal-title":"Science"},{"key":"BFtp2015101_CR4","unstructured":"UNDCP\/WHO. United Nations International Drug Control Programme and World Health Organization Technical Report Series (No. V92-54439T) United Nations International Drug Control Programme: Vienna, Austria 1992."},{"key":"BFtp2015101_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06298.x","volume":"1248","author":"ST Tiffany","year":"2012","unstructured":"Tiffany ST, Wray JM . The clinical significance of drug craving. Ann N Y Acad Sci 2012; 1248: 1\u201317.","journal-title":"Ann N Y Acad Sci"},{"key":"BFtp2015101_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/bmj.327.7410.310","volume":"327","author":"W van den Brink","year":"2003","unstructured":"van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM et al. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003; 327: 310.","journal-title":"BMJ"},{"key":"BFtp2015101_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1874473711205010003","volume":"5","author":"W van den Brink","year":"2012","unstructured":"van den Brink W . Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev 2012; 5: 3\u201331.","journal-title":"Curr Drug Abuse Rev"},{"key":"BFtp2015101_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1037\/0021-843X.97.2.118","volume":"97","author":"RA Wise","year":"1988","unstructured":"Wise RA . The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 1988; 97: 118\u2013132.","journal-title":"J Abnorm Psychol"},{"key":"BFtp2015101_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","volume":"164","author":"G Koob","year":"2007","unstructured":"Koob G, Kreek MJ . Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007; 164: 1149\u20131159.","journal-title":"Am J Psychiatry"},{"key":"BFtp2015101_CR10","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1360-0443.1992.tb02001.x","volume":"87","author":"J Cami","year":"1992","unstructured":"Cami J, Gilabert M, San L, de la Torre R . Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Br J Addict 1992; 87: 1145\u20131151.","journal-title":"Br J Addict"},{"key":"BFtp2015101_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","volume":"51","author":"MJ Kreek","year":"1998","unstructured":"Kreek MJ, Koob GF . Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 1998; 51: 23\u201347.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp2015101_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1749-6632.1982.tb39489.x","volume":"398","author":"MJ Kreek","year":"1982","unstructured":"Kreek MJ, Hartman N . Chronic use of opioids and antipsychotic drugs: side effects, effects on endogenous opioids, and toxicity. Ann N Y Acad Sci 1982; 398: 151\u2013172.","journal-title":"Ann N Y Acad Sci"},{"key":"BFtp2015101_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.euroneuro.2008.01.005","volume":"18","author":"M Walter","year":"2008","unstructured":"Walter M, Wiesbeck GA, Bloch N, Aeschbach S, Olbrich HM, Seifritz E et al. Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study. Eur Neuropsychopharmacol 2008; 18: 390\u2013393.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2015101_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1369-1600.2010.00205.x","volume":"16","author":"M Walter","year":"2011","unstructured":"Walter M, Wiesbeck GA, Degen B, Albrich J, Oppel M, Schulz A et al. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol 2011; 16: 145\u2013151.","journal-title":"Addict Biol"},{"key":"BFtp2015101_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/JCP.0b013e31828393cb","volume":"33","author":"M Walter","year":"2013","unstructured":"Walter M, Gerber H, Kuhl HC, Schmid O, Joechle W, Lanz C et al. Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trial. J Clin Psychopharmacol 2013; 33: 193\u2013198.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtp2015101_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.biopsych.2013.10.019","volume":"76","author":"A Schmidt","year":"2014","unstructured":"Schmidt A, Borgwardt S, Gerber H, Wiesbeck GA, Schmid O, Riecher-R\u00f6ssler A et al. Acute effects of heroin on negative emotional processing: relation of amygdala activity and stress-related responses. Biol Psychiatry 2014; 76: 289\u2013296.","journal-title":"Biol Psychiatry"},{"key":"BFtp2015101_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.psyneuen.2014.12.004","volume":"52","author":"AK Bershad","year":"2015","unstructured":"Bershad AK, Jaffe JH, Childs E, de Wit H . Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans. Psychoneuroendocrinology 2015; 52: 281\u2013288.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp2015101_CR18","first-page":"125","volume":"25","author":"J Stewart","year":"2000","unstructured":"Stewart J . Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 2000; 25: 125\u2013136.","journal-title":"J Psychiatry Neurosci"},{"key":"BFtp2015101_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00213-011-2183-x","volume":"218","author":"KL Preston","year":"2011","unstructured":"Preston KL, Epstein DH . Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology (Berl) 2011; 218: 29\u201337.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2015101_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1176\/appi.ajp.2011.11020180","volume":"168","author":"TR Kosten","year":"2011","unstructured":"Kosten TR . Stress and addiction. Am J Psychiatry 2011; 168: 566\u2013568.","journal-title":"Am J Psychiatry"},{"key":"BFtp2015101_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.yfrne.2009.03.002","volume":"30","author":"DJ de Quervain","year":"2009","unstructured":"de Quervain DJ, Aerni A, Schelling G, Roozendaal B . Glucocorticoids and the regulation of memory in health and disease. Front Neuroendocrinol 2009; 30: 358\u2013370.","journal-title":"Front Neuroendocrinol"},{"key":"BFtp2015101_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neuron.2004.09.016","volume":"44","author":"AE Kelley","year":"2004","unstructured":"Kelley AE . Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004; 44: 161\u2013179.","journal-title":"Neuron"},{"key":"BFtp2015101_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/35094560","volume":"2","author":"SE Hyman","year":"2001","unstructured":"Hyman SE, Malenka RC . Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695\u2013703.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2015101_CR24","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.euroneuro.2012.11.007","volume":"23","author":"KH Preller","year":"2013","unstructured":"Preller KH, Wagner M, Sulzbach C, Hoenig K, Neubauer J, Franke PE et al. Sustained incentive value of heroin-related cues in short- and long-term abstinent heroin users. Eur Neuropsychopharmacol 2013; 23: 1270\u20131279.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2015101_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1360-0443.1999.9433273.x","volume":"94","author":"BL Carter","year":"1999","unstructured":"Carter BL, Tiffany ST . Meta-analysis of cue-reactivity in addiction research. Addiction 1999; 94: 327\u2013340.","journal-title":"Addiction"},{"issue":"Suppl 2","key":"BFtp2015101_CR26","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","volume":"95","author":"TE Robinson","year":"2000","unstructured":"Robinson TE, Berridge KC . The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000; 95 (Suppl 2): S91\u2013117.","journal-title":"Addiction"},{"key":"BFtp2015101_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neuropharm.2006.08.021","volume":"52","author":"AA Sajadi","year":"2007","unstructured":"Sajadi AA, Samaei SA, Rashidy-Pour A . Blocking effects of intra-hippocampal naltrexone microinjections on glucocorticoid-induced impairment of spatial memory retrieval in rats. Neuropharmacology 2007; 52: 347\u2013354.","journal-title":"Neuropharmacology"},{"key":"BFtp2015101_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s001080050385","volume":"40","author":"T Steffen","year":"1999","unstructured":"Steffen T, Uchtenhagen A, Gutzwiller F, Dobler-Mikola A, Blattler R . [Heroin-assisted treatment of opiate dependent patients. Experiences from Swiss trials for medical prescription of narcotics (PROVE)]. Internist (Berl) 1999; 40: 651\u2013656.","journal-title":"Internist (Berl)"},{"key":"BFtp2015101_CR29","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1073\/pnas.1018214108","volume":"108","author":"DJ de Quervain","year":"2011","unstructured":"de Quervain DJ, Bentz D, Michael T, Bolt OC, Wiederhold BK, Margraf J et al. Glucocorticoids enhance extinction-based psychotherapy. Proc Natl Acad Sci USA 2011; 108: 6621\u20136625.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2015101_CR30","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1073\/pnas.0509184103","volume":"103","author":"LM Soravia","year":"2006","unstructured":"Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U et al. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci USA 2006; 103: 5585\u20135590.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2015101_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0376-8716(98)00108-2","volume":"53","author":"NE Goeders","year":"1998","unstructured":"Goeders NE, Peltier RL, Guerin GF . Ketoconazole reduces low dose cocaine self-administration in rats. Drug Alcohol Depend 1998; 53: 67\u201377.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp2015101_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/00008877-199811000-00013","volume":"9","author":"AS Ward","year":"1998","unstructured":"Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW . Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans. Behav Pharmacol 1998; 9: 577\u2013586.","journal-title":"Behav Pharmacol"},{"key":"BFtp2015101_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0376-8716(01)00198-3","volume":"66","author":"TR Kosten","year":"2002","unstructured":"Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A . Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug Alcohol Depend 2002; 66: 173\u2013180.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp2015101_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/29542","volume":"394","author":"DJF de Quervain","year":"1998","unstructured":"de Quervain DJF, Roozendaal B, McGaugh JL . Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998; 394: 787\u2013790.","journal-title":"Nature"},{"key":"BFtp2015101_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/73873","volume":"3","author":"DJF de Quervain","year":"2000","unstructured":"de Quervain DJF, Roozendaal B, Nitsch RM, McGaugh JL, Hock C . Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 2000; 3: 313\u2013314.","journal-title":"Nat Neurosci"},{"key":"BFtp2015101_CR36","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1176\/ajp.2007.164.6.967","volume":"164","author":"DJ de Quervain","year":"2007","unstructured":"de Quervain DJ, Aerni A, Roozendaal B . Preventive effect of {beta}-adrenoceptor blockade on glucocorticoid-induced memory retrieval deficits. Am J Psychiatry 2007; 164: 967\u2013969.","journal-title":"Am J Psychiatry"},{"key":"BFtp2015101_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1176\/appi.ajp.161.8.1488","volume":"161","author":"A Aerni","year":"2004","unstructured":"Aerni A, Traber R, Hock C, Roozendaal B, Schelling G, Papassotiropoulos A et al. Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 2004; 161: 1488\u20131490.","journal-title":"Am J Psychiatry"},{"key":"BFtp2015101_CR38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nn.3498","volume":"16","author":"FJ Munoz-Cuevas","year":"2013","unstructured":"Munoz-Cuevas FJ, Athilingam J, Piscopo D, Wilbrecht L . Cocaine-induced structural plasticity in frontal cortex correlates with conditioned place preference. Nat Neurosci 2013; 16: 1367\u20131369.","journal-title":"Nat Neurosci"},{"key":"BFtp2015101_CR39","doi-asserted-by":"publisher","first-page":"11800","DOI":"10.1523\/JNEUROSCI.1969-13.2013","volume":"33","author":"EN Graf","year":"2013","unstructured":"Graf EN, Wheeler RA, Baker DA, Ebben AL, Hill JE, McReynolds JR et al. Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking. J Neurosci 2013; 33: 11800\u201311810.","journal-title":"J Neurosci"},{"key":"BFtp2015101_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.psyneuen.2014.04.022","volume":"47","author":"ER Montoya","year":"2014","unstructured":"Montoya ER, Bos PA, Terburg D, Rosenberger LA, van Honk J . Cortisol administration induces global down-regulation of the brain's reward circuitry. Psychoneuroendocrinology 2014; 47: 31\u201342.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp2015101_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000073725","volume":"10","author":"P Gschwend","year":"2004","unstructured":"Gschwend P, Rehm J, Bl\u00e4ttler R, Steffen T, Seidenberg A, Christen S et al. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland\u2014Swiss national cohort study. Eur Addict Res 2004; 10: 41\u201348.","journal-title":"Eur Addict Res"},{"key":"BFtp2015101_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","volume":"30","author":"JC Veilleux","year":"2010","unstructured":"Veilleux JC, Colvin PJ, Anderson J, York C, Heinz AJ . A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 2010; 30: 155\u2013166.","journal-title":"Clin Psychol Rev"},{"key":"BFtp2015101_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijpsycho.2005.10.012","volume":"59","author":"N Rohleder","year":"2006","unstructured":"Rohleder N, Kirschbaum C . The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int J Psychophysiol 2006; 59: 236\u2013243.","journal-title":"Int J Psychophysiol"},{"key":"BFtp2015101_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1037\/1064-1297.15.5.445","volume":"15","author":"R Sinha","year":"2007","unstructured":"Sinha R, Fox H, Hong KI, Sofuoglu M, Morgan PT, Bergquist KT . Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility. Exp Clin Psychopharmacol 2007; 15: 445\u2013452.","journal-title":"Exp Clin Psychopharmacol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp2015101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2015101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2015101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:01:35Z","timestamp":1718002895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2015101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"alternative-id":["BFtp2015101"],"URL":"https:\/\/doi.org\/10.1038\/tp.2015.101","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]},"assertion":[{"value":"25 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}